Table Filtering
Other Information
Release Statistics Download
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 13401 - 13425 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:10584 retinitis pigmentosa HGNC:10012 Homo sapiens (human) 6010 RHO mutant phenotype evidence used in manual assertion
  • PMID:21268285
DOID:9119 acute myeloid leukemia HGNC:6156 Homo sapiens (human) 3690 ITGB3 mutant phenotype evidence used in manual assertion
  • PMID:23770013
DOID:3721 plasmacytoma HGNC:10249 Homo sapiens (human) 6091 ROBO1 mutant phenotype evidence used in manual assertion
  • PMID:34268498
DOID:0050908 myelodysplastic syndrome HGNC:18318 Homo sapiens (human) 171023 ASXL1 mutant phenotype evidence used in manual assertion
  • PMID:24216483
DOID:784 chronic kidney disease RGD:3001 Rattus norvegicus (Norway rat) 24536 Lepr mutant phenotype evidence used in manual assertion
  • PMID:27465994
  • PMID:32390513
DOID:2526 prostate adenocarcinoma HGNC:6091 Homo sapiens (human) 3643 INSR mutant phenotype evidence used in manual assertion
  • PMID:26452103
DOID:10283 prostate cancer RGD:3285 Rattus norvegicus (Norway rat) 24629 Pdgfrb mutant phenotype evidence used in manual assertion
  • PMID:17854058
DOID:11446 sciatic neuropathy RGD:3629 Rattus norvegicus (Norway rat) 29571 Scn10a mutant phenotype evidence used in manual assertion
  • PMID:21965668
DOID:1289 neurodegenerative disease WB:WBGene00001612 Caenorhabditis elegans 176204 glr-1 mutant phenotype evidence used in manual assertion
  • PMID:31306683
DOID:1826 epilepsy WB:WBGene00002081 Caenorhabditis elegans 176296 ina-1 mutant phenotype evidence used in manual assertion
  • PMID:19797046
DOID:2526 prostate adenocarcinoma HGNC:392 Homo sapiens (human) 208 AKT2 mutant phenotype evidence used in manual assertion
  • PMID:20638364
DOID:1612 breast cancer HGNC:590 Homo sapiens (human) 329 BIRC2 mutant phenotype evidence used in manual assertion
  • PMID:12218061
DOID:3007 breast ductal carcinoma HGNC:28611 Homo sapiens (human) 253260 RICTOR mutant phenotype evidence used in manual assertion
  • PMID:20978191
DOID:2526 prostate adenocarcinoma HGNC:8976 Homo sapiens (human) 5291 PIK3CB mutant phenotype evidence used in manual assertion
  • PMID:18755892
DOID:3213 demyelinating disease RGD:2906 Rattus norvegicus (Norway rat) 29385 Cxcr2 mutant phenotype evidence used in manual assertion
  • PMID:19616545
DOID:9119 acute myeloid leukemia HGNC:3688 Homo sapiens (human) 2260 FGFR1 mutant phenotype evidence used in manual assertion
  • PMID:22683780
  • PMID:23777766
  • PMID:27005999
DOID:12858 Huntington's disease RGD:620349 Rattus norvegicus (Norway rat) 29527 Ptgs2 mutant phenotype evidence used in manual assertion
  • PMID:21362433
DOID:12802 mucopolysaccharidosis I HGNC:5391 Homo sapiens (human) 3425 IDUA mutant phenotype evidence used in manual assertion
  • PMID:12948739
  • PMID:15194053
  • PMID:17407189
  • PMID:18523448
  • PMID:25597593
DOID:0081312 T-cell non-Hodgkin lymphoma HGNC:3688 Homo sapiens (human) 2260 FGFR1 mutant phenotype evidence used in manual assertion
  • PMID:19506298
DOID:299 adenocarcinoma RGD:620349 Rattus norvegicus (Norway rat) 29527 Ptgs2 mutant phenotype evidence used in manual assertion
  • PMID:17675820
DOID:10914 amnestic disorder RGD:71034 Rattus norvegicus (Norway rat) 65032 Htr7 mutant phenotype evidence used in manual assertion
  • PMID:18570192
DOID:0060246 MASA syndrome WB:WBGene00002243 Caenorhabditis elegans 177078 lad-2 mutant phenotype evidence used in manual assertion
  • PMID:18195110
DOID:583 hemolytic anemia HGNC:3616 Homo sapiens (human) 2212 FCGR2A mutant phenotype evidence used in manual assertion
  • PMID:15982355
DOID:684 hepatocellular carcinoma HGNC:18037 Homo sapiens (human) 196528 ARID2 mutant phenotype evidence used in manual assertion
  • PMID:27351279
DOID:10763 hypertension RGD:3371 Rattus norvegicus (Norway rat) 25664 Pparg mutant phenotype evidence used in manual assertion
  • PMID:18437150

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025